Prevalence of Insomnia in the Early Post-COVID-19 Recovery Period

Robert Pudlo (), Izabela Jaworska, Anna Szczegielniak, Jacek Niedziela, Zofia Kułaczkowska, Alicja Nowowiejska-Wiewióra, Jerzy Jaroszewicz and Mariusz Gąsior
Additional contact information
Robert Pudlo: Department of Psychoprophylaxis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
Izabela Jaworska: Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
Anna Szczegielniak: Department of Psychoprophylaxis, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
Jacek Niedziela: 3rd Department of Cardiology, Silesian Center for Heart Disease, 41-800 Zabrze, Poland
Zofia Kułaczkowska: 3rd Department of Cardiology, Silesian Center for Heart Disease, 41-800 Zabrze, Poland
Alicja Nowowiejska-Wiewióra: 3rd Department of Cardiology, Silesian Center for Heart Disease, 41-800 Zabrze, Poland
Jerzy Jaroszewicz: Department of Infectious Diseases and Hepatology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
Mariusz Gąsior: 3rd Department of Cardiology, Silesian Center for Heart Disease, 41-800 Zabrze, Poland

IJERPH, 2022, vol. 19, issue 21, 1-17

Abstract: Background: Sleep is a complex, reversible process that is responsible for the modulation of various physiological mechanisms. COVID-19-related sleep disorders are affecting different populations with a heterogenous prevalence, yet high rates among infected patients are frequently reported. The aim of the study is to assess the prevalence of insomnia in the early post-COVID-19 recovery period and explore the differences in the results acquired by the Athens Insomnia Scale (AIS) by gender and selected infection severity parameters. Methods: The data presented in the paper come from a prospective, observational study on COVID-19 complications (SILCOV-19) consisting of 200 COVID-19 patients. The AIS was used for the quantitative measurement of insomnia symptoms based on ICD-10 criteria. Results: 32% ( n = 64) of all patients in the study group obtained results indicating sleep disturbances (>5 points on the scale), while 21.5% ( n = 43) obtained results indicating insomnia (>10 points on the scale). The analysis of the results obtained by all patients in the AIS showed a significant correlation with the duration of symptoms (Spearman’s rank-order: R = 0.18; p < 0.05), but not with the number of days spent in the hospital or age. Women achieved a higher score in overall AIS, as well as in questions assessing total sleep time, well-being the next day, physical and mental fitness the next day, and sleepiness during the day ( p < 0.05). Conclusions: the prevalence of insomnia in the early post-COVID-19 recovery period is high.

Keywords: COVID-19; post-COVID-19 syndrome; insomnia; sleep disorders; Athens Insomnia Scale (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/19/21/14224/pdf (application/pdf)
https://www.mdpi.com/1660-4601/19/21/14224/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:19:y:2022:i:21:p:14224-:d:958602

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().